Daytime alertness, insomnia, and benzodiazepines.
D000328:Adult; D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001143:Arousal / Q000187:drug effects*; D001569:Benzodiazepines / Q000627:therapeutic use; D004311:Double-Blind Method; D005479:Flurazepam / Q000627:therapeutic use; D006801:Humans; D008140:Lorazepam / Q000031:analogs & derivatives / Q000627:therapeutic use; D008297:Male; D010076:Oxazepam / Q000627:therapeutic use; D012892:Sleep Deprivation; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D012894:Sleep Stages / Q000187:drug effects; D014229:Triazolam / Q000627:therapeutic use; D014851:Wakefulness / Q000187:drug effects
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D014229:Triazolam; D010076:Oxazepam; C023842:lormetazepam; D005479:Flurazepam; C025130:quazepam; D008140:Lorazepam